NO992468L - Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID - Google Patents

Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID

Info

Publication number
NO992468L
NO992468L NO992468A NO992468A NO992468L NO 992468 L NO992468 L NO 992468L NO 992468 A NO992468 A NO 992468A NO 992468 A NO992468 A NO 992468A NO 992468 L NO992468 L NO 992468L
Authority
NO
Norway
Prior art keywords
nsaids
treatment
composition
gastrointestinal disorders
containing bismuth
Prior art date
Application number
NO992468A
Other languages
English (en)
Norwegian (no)
Other versions
NO992468D0 (no
Inventor
Jonathan Davidson Kaunitz
Owen Rickford Carryl
Shin Tanaka
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO992468D0 publication Critical patent/NO992468D0/no
Publication of NO992468L publication Critical patent/NO992468L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO992468A 1996-11-22 1999-05-21 Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID NO992468L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75551796A 1996-11-22 1996-11-22
PCT/US1997/021462 WO1998022118A1 (fr) 1996-11-22 1997-11-21 Compositions et methodes pour traiter des troubles gastro-intestinaux

Publications (2)

Publication Number Publication Date
NO992468D0 NO992468D0 (no) 1999-05-21
NO992468L true NO992468L (no) 1999-07-01

Family

ID=25039481

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992468A NO992468L (no) 1996-11-22 1999-05-21 Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID

Country Status (7)

Country Link
EP (1) EP0941102A1 (fr)
CN (1) CN1238694A (fr)
CA (1) CA2271381A1 (fr)
HU (1) HUP9904073A3 (fr)
NO (1) NO992468L (fr)
TR (1) TR199901101T2 (fr)
WO (1) WO1998022118A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
AU781133B2 (en) * 1999-02-26 2005-05-05 Nicox S.A. Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
TWI275587B (en) * 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
US7285668B2 (en) * 2000-12-01 2007-10-23 Takeda Pharmaceutical Company Limited Process for the crystallization of (R)- or (S)-lansoprazole
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US6514960B1 (en) * 2001-08-27 2003-02-04 Hedonist Biochemical Technologies Co., Ltd. Use of bismuth subgallate in inhibition of production of nitric oxide synthase
US7211590B2 (en) 2002-08-01 2007-05-01 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
AU2003273000A1 (en) 2002-10-16 2004-05-04 Takeda Pharmaceutical Company Limited Stable solid preparations
CA2570916C (fr) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Forme posologique d'ipp a doses multiples
KR101148399B1 (ko) * 2005-06-22 2012-05-23 일양약품주식회사 항궤양제 및 점막보호제를 함유하는 경구용 위장질환치료용 약제 조성물
JP2011513202A (ja) 2008-03-10 2011-04-28 武田薬品工業株式会社 ベンズイミダゾール化合物の結晶
CA2736547C (fr) 2008-09-09 2016-11-01 Pozen Inc. Procede d'administration d'une composition pharmaceutique a un patient en ayant besoin
AU2010263304A1 (en) 2009-06-25 2012-02-02 Astrazeneca Ab Method for treating a patient at risk for developing an NSAID-associated ulcer
MX2014007935A (es) 2011-12-28 2014-11-14 Pozen Inc Composiciones y metodos mejorados para el suministro de omeprazol y de acido acetilsalicilico.
WO2023143573A1 (fr) * 2022-01-30 2023-08-03 上海石趣医药科技有限公司 Utilisation d'un composé contenant du bismuth dans un traitement de maladies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI910088A (fi) * 1990-01-09 1991-07-10 Gist Brocades Nv Oral farmaceutisk komposition.
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
WO1993009784A1 (fr) * 1991-11-22 1993-05-27 The Procter & Gamble Company Preparation pharmaceutique de doses unitaires de subsalicylate de bismuth
ES2130152T3 (es) * 1991-12-06 1999-07-01 Glaxo Group Ltd Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.

Also Published As

Publication number Publication date
HUP9904073A3 (en) 2000-04-28
HUP9904073A2 (hu) 2000-03-28
WO1998022118A1 (fr) 1998-05-28
EP0941102A1 (fr) 1999-09-15
TR199901101T2 (xx) 1999-07-21
NO992468D0 (no) 1999-05-21
CN1238694A (zh) 1999-12-15
CA2271381A1 (fr) 1998-05-28

Similar Documents

Publication Publication Date Title
NO992468L (no) Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID
NZ235877A (en) Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
NO992469L (no) Sammensetninger inneholdende vismut og NSAID samt ett eller fler anti-mikrobielle midler til behandling av gastrointestinale lidelser
DK0963200T3 (da) Præparater til inhibering af angiogenese omfattende thalidomid og et NSAID
DK0754176T3 (da) Hidtil ukendte carbamater og urinstoffer som modifikatorer for multidrugsresistens
DK0862424T3 (da) Farmaceutiske præparater omfattende flurbiprofen
ATE525061T1 (de) Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut
DK1024815T3 (da) Farmaceutisk sammensætning til oral administrering af molekylært iod
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
PT705100E (pt) Guanidinas substituidas terapeuticas
NO976048L (no) Farmasöytiske og diett formuleringer for profylakse og behandling av mave- og tarmforstyrrelser
ATE106737T1 (de) Pharmazeutische zusammensetzungen zur behandlung gastrointestinaler störungen.
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
PL323617A1 (en) Pharmaceutical preparation for treating oestrogen-dependent carcinomas
DE69927584D1 (de) Pharmazeutische zubereitungen zur behandlung von magengeschwüren
TR199800421A2 (xx) Moenomisin grubu antibiyotiklerin bizmut tuzlar�.
MX9305510A (es) Compuestos para el tratamiento o profilaxis de desordenes gastrointestinales, cardiovasculares y del sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
DK554585D0 (da) Laegemiddel omfattende en forbindelse af mindst et immunotoxin og mindst en mannoseholdig polymer
DK1073436T3 (da) Forbedret fremgangsmåde til udryddelse af helicobacter pylori
NO982562L (no) Sammensetning for behandling av smerte
IL127143A0 (en) Phospholipid terivatives of non-steroidal anti inflammatory drugs
ATE44461T1 (de) Analgetische zusammensetzungen.
FR2707455B1 (fr) Empêchement de la reproduction des insectes xylophages, moyens pour le traitement préventif du matériau bois mis en Óoeuvre.
SE8504612L (sv) Analgetiska och antiinflammatoriska kompositioner innefattande difenhydramin och forfaranden for anvendning av dessa

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application